Related Experiment Video

Updated: Jun 3, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Carotid intima-media thickness and cardiovascular risk

Farouk Mookadam1, Weerawat Tanasunont, Uzma Jalal

  • 1Department of Cardiovascular Diseases, Mayo Clinic Scottsdale, AZ, USA. mookadam.farouk@mayo.edu

Future Cardiology
|April 2, 2011
PubMed

Insights

Carotid intima-media thickness (CIMT) ultrasonography is a valuable tool for assessing cardiovascular risk. This noninvasive method helps identify atherosclerosis in asymptomatic individuals, improving cardiovascular event prediction.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality globally.
  • Current risk stratification methods using risk scores may not accurately identify atherosclerosis in asymptomatic individuals.
  • Noninvasive imaging is needed for reliable CVD risk assessment.

Purpose of the Study:

  • To evaluate carotid intima-media thickness (CIMT) as a tool for cardiovascular risk stratification.
  • To highlight the utility of CIMT ultrasonography in identifying subclinical atherosclerosis.
  • To assess the role of CIMT as an independent predictor of cardiovascular events.

Main Methods:

  • Utilizing ultrasonography to measure carotid intima-media thickness (CIMT).
  • Analyzing CIMT as a surrogate marker for subclinical atherosclerosis.
  • Correlating CIMT measurements with established cardiovascular risk factors and future events.

Main Results:

  • Carotid intima-media thickness (CIMT) is a well-validated, noninvasive measure.
  • CIMT demonstrates utility as an independent predictor of future cardiovascular events.
  • Recent data support CIMT's application as a screening tool for cardiovascular disease.

Conclusions:

  • Carotid intima-media thickness (CIMT) ultrasonography offers significant value in cardiovascular risk assessment.
  • CIMT can identify atherosclerosis in individuals without traditional risk factors.
  • CIMT measurement improves the identification and prediction of cardiovascular disease.

More Related Videos

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...